Our state-of-the-art Nottingham facility houses 10 GMP manufacturing suites, quality control laboratories and dedicated analytical and formulation development laboratories with pilot plant facilities.
Trent Gateway has been specifically designed to cater to a wide range of development and manufacturing projects, offering processing of non-sterile dosage forms including solids, liquids, semi-solids, nasal and inhaled products, alongside sterile liquid and dry powder drug products.
Whether you’re in the early stages of formulation development, in need of clinical trial supplies from Phase 1 to Phase 3 or seeking niche-scale commercial manufacturing, Trent Gateway is fully equipped to fulfill your requirements with precision and excellence.
Integrated GMP manufacturing suites supporting development and clinical manufacture.
Containment capabilities supporting the safe handling of highly potent compounds up to OEB 5.
MHRA Approved sterile manufacturing facility, designed against the revised Annex -1 guidelines.
R&D, GMP, QC and more all on one 70,000 sq ft facility in Nottingham, UK
sq. ft sterile manufacturing facility
Initial batch sizes, up to 2,000 units
MHRA Approved sterile manufacturing facility, designed against the revised Annex -1 guidelines.
Flexible sterile filling capability supporting vial formats from 2R to 20R.
Join one of our subject matter experts for a guided virtual tour of the facility. Discover our development laboratories, analytical capabilities, GMP manufacturing suites and sterile processing environments, and see how programmes progress from feasibility through clinical manufacture on a single integrated site.